Skip to main content

Dr. Alexander Asam, MBA
Investment advisor

More than 20 years of experience in the life sciences and private equity businesses. Former managing director and partner of Deutsche Venture Capital (DVC) / Deutsche Bank. Various positions at Hoechst AG, Aventis S.A. (now: Sanofi) and LION Bioscience AG, among others member of the IPO Core Team (dual listing Germany and USA). MBA degree from ASTON Business School, Birmingham and a MSc and PhD in chemistry from University of Heidelberg. Board member of APR Applied Pharma Research, ATI Autonomic Technologies, MIKA Pharma, Sublimity Therapeutics. Board observer at Corvidia Therapeutics and Vitaeris.